Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 72

1.

Interactions of protease inhibitors atazanavir and ritonavir with ABCB1, ABCG2, and ABCC2 transporters: Effect on transplacental disposition in rats.

Cerveny L, Ptackova Z, Durisova M, Staud F.

Reprod Toxicol. 2018 Aug;79:57-65. doi: 10.1016/j.reprotox.2018.05.008. Epub 2018 May 30.

PMID:
29859254
2.

Analysis of immune cell populations in atrial myocardium of patients with atrial fibrillation or sinus rhythm.

Smorodinova N, Bláha M, Melenovský V, Rozsívalová K, Přidal J, Ďurišová M, Pirk J, Kautzner J, Kučera T.

PLoS One. 2017 Feb 22;12(2):e0172691. doi: 10.1371/journal.pone.0172691. eCollection 2017.

3.

Intelligent Soft Computing on Forex: Exchange Rates Forecasting with Hybrid Radial Basis Neural Network.

Falat L, Marcek D, Durisova M.

ScientificWorldJournal. 2016;2016:3460293. doi: 10.1155/2016/3460293. Epub 2016 Feb 8.

4.

A physiological view and structures of mean residence times.

Durišová M.

Gen Physiol Biophys. 2014;33(1):75-80. doi: 10.4149/gpb_2013060. Epub 2013 Dec 13.

PMID:
24334531
5.

Physiologically based structure of mean residence time.

Durišová M.

ScientificWorldJournal. 2012;2012:610631. doi: 10.1100/2012/610631. Epub 2012 Apr 1.

6.

Effect of gastric emptying and entero-hepatic circulation on bioequivalence assessment of ranitidine.

Chrenova J, Durisova M, Mircioiu C, Dedik L.

Methods Find Exp Clin Pharmacol. 2010 Jul-Aug;32(6):413-9. doi: 10.1358/mf.2010.32.6.1472184.

PMID:
20852750
7.

Novel approach to bioequivalence assessment based on physiologically motivated model.

Tvrdonova M, Chrenova J, Rausova Z, Miklovicova D, Durisova M, Mircioiu C, Dedik L.

Int J Pharm. 2009 Oct 1;380(1-2):89-95. doi: 10.1016/j.ijpharm.2009.07.004. Epub 2009 Jul 22.

PMID:
19596057
8.

Computer controlled sequential simulation method: reconsidering evaluation of measurements from frequently sampled intravenous glucose tolerance test.

Dedík L, Tvrdonová M, Durisová M, Penesová A, Miklovicová D, Kozlovský M.

Comput Methods Programs Biomed. 2009 Jul;95(1):1-9. doi: 10.1016/j.cmpb.2009.01.001. Epub 2009 Feb 26.

PMID:
19249114
9.

Physiologically motivated time-delay model to account for mechanisms underlying enterohepatic circulation of piroxicam in human beings.

Tvrdonova M, Dedik L, Mircioiu C, Miklovicova D, Durisova M.

Basic Clin Pharmacol Toxicol. 2009 Jan;104(1):35-42. doi: 10.1111/j.1742-7843.2008.00304.x.

10.

Mathematical model indicates nonlinearity of noradrenaline effect on rat renal artery.

Durisová M, Dedík L, Kristová V, Vojtko R.

Physiol Res. 2008;57(5):785-8. Epub 2007 Oct 11.

11.

Numerical simulations of stochastic circulatory models.

Wimmer G, Dedík L, Michal M, Mudríková A, Durisová M.

Bull Math Biol. 1999 Mar;61(2):365-77.

PMID:
17883215
12.

Estimation of influence of gastric emptying on shape of glucose concentration-time profile measured in oral glucose tolerance test.

Dedík L, Durisová M, Penesová A, Miklovicová D, Tvrdonová M.

Diabetes Res Clin Pract. 2007 Sep;77(3):377-84. Epub 2007 Jan 30.

PMID:
17270310
13.

Modeling behavior of protein C during and after subcutaneous administration.

Chaubal MV, Dedík L, Durisová M, Bruley DF.

Adv Exp Med Biol. 2005;566:389-95.

PMID:
16594177
14.

New mathematical methods in pharmacokinetic modeling.

Durisová M, Dedík L.

Basic Clin Pharmacol Toxicol. 2005 May;96(5):335-42. Review.

15.

Computer-based methods for measurement, recording and modeling vessel responses in vitro: a pilot study with noradrenaline.

Dedík L, Durisová M, Svrcek V, Vojtko R, Kristová V, Kriska M.

Methods Find Exp Clin Pharmacol. 2003 Jul-Aug;25(6):441-45.

PMID:
12949629
16.

A system-approach method for the adjustment of time-varying continuous drug infusion in individual patients: a simulation study.

Durisová M, Dedík L.

J Pharmacokinet Pharmacodyn. 2002 Dec;29(5-6):427-44. Erratum in: J Pharmacokinet Pharmacodyn. 2003 Jun;30(3):237.

PMID:
12795240
17.

System approach to modeling metabolite formation from parent drug: a working example with methotrexate.

Dedík L, Durisová M.

Methods Find Exp Clin Pharmacol. 2002 Oct;24(8):481-6.

PMID:
12500426
18.

System-approach methods for modeling and testing similarity of in vitro dissolutions of drug dosage formulations.

Dedík L, Durisová M.

Comput Methods Programs Biomed. 2002 Jul;69(1):49-55.

PMID:
12088592
19.

Modeling drug absorption from enteric-coated granules.

Dedík L, Durisová M.

Methods Find Exp Clin Pharmacol. 2001 Jun;23(5):213-7.

PMID:
11712638
20.

Weighting function used for adjustment of multiple-bolus drug dosing.

Dedík L, Durisová M, Bátorová A.

Methods Find Exp Clin Pharmacol. 2000 Sep;22(7):543-9.

PMID:
11196341
21.

Model of lymphocyte migration in Merino ewes under physiological conditions.

Dedík L, Durisová M, Srikusalanukul W, McCullagh P.

Physiol Res. 1999;48(6):525-8.

22.

Pharmacokinetic study of stobadine.

Bezek S, Soltés L, Scasnár V, Bauerová K, Kállay Z, Durisová M, Mihalová D, Bohov P, Faberová V, Kukan M, Trnovec T, Koprda V.

Life Sci. 1999;65(18-19):2003-5.

PMID:
10576455
23.

Bioavailability and pharmacokinetic studies in the development of an oral formulation of stobadine dipalmitate.

Bauerová K, Bohov P, Durisová M, Bezek S.

Methods Find Exp Clin Pharmacol. 1999 Sep;21(7):499-503.

PMID:
10544395
24.

Pharmacokinetics of factor VIII in hemophilia A patients assessed by frequency response method.

Durisová M, Dedík L, Bátorová A, Sakalová A, Hedera J.

Methods Find Exp Clin Pharmacol. 1998 Apr;20(3):217-26.

PMID:
9646284
25.

Modeling in frequency domain used for assessment of in vivo dissolution profile.

Durisová M, Dedík L.

Pharm Res. 1997 Jul;14(7):860-4.

PMID:
9244141
26.

New general formulas for estimation of mean residence time and its variance.

Dedik L, Durisová M.

Pharmazie. 1997 May;52(5):404-5. No abstract available.

PMID:
9183795
27.

Effect of long-term administration of stobadine on exploratory behaviour and on striatal levels of dopamine and serotonin in rats and their offspring.

Dubovický M, Ujházy E, Kovacovský P, Rychlík I, Kalnovicová T, Navarová J, Turcáni P, Durisová M, Gajdosík A.

J Appl Toxicol. 1997 Jan-Feb;17(1):63-70.

PMID:
9048229
28.

CXT-MAIN: a software package for determination of the analytical form of the pharmacokinetic system weighting function.

Dedík L, Durisová M.

Comput Methods Programs Biomed. 1996 Nov;51(3):183-92.

PMID:
8955587
29.

Determination of analytical form of system weighting function.

Durisová M, Dedík L.

Methods Find Exp Clin Pharmacol. 1996 Jul-Aug;18(6):407-12.

PMID:
8892270
30.

Building a structured model of a complex pharmacokinetic system with time delays.

Durisová M, Dedík L, Balan M.

Bull Math Biol. 1995 Nov;57(6):787-808.

PMID:
8528156
31.

CXT: a programme for analysis of linear dynamic systems in the frequency domain.

Dedík L, Durisová M.

Int J Biomed Comput. 1995 May;39(2):231-41.

PMID:
7672867
32.

[Transplacental transfer of stobadine in rabbits in various stages of pregnancy--an approximation using a pharmacokinetic model].

Ujházy E, Faberová V, Dubovický M, Zemánek M, Jansák J, Dedík L, Durisová M.

Cesk Fysiol. 1995 Mar;44(1):15-7. Slovak.

PMID:
7758141
33.

Frequency response method in pharmacokinetics.

Dedík L, Durisová M.

J Pharmacokinet Biopharm. 1994 Aug;22(4):293-307.

PMID:
7699584
34.

Comparative study of human pentacaine pharmacokinetics in time and frequency domain.

Durisová M, Dedík L.

Methods Find Exp Clin Pharmacol. 1994 Apr;16(3):219-32.

PMID:
8046954
36.

Teratogenicity of cyclophosphamide in New Zealand white rabbits.

Ujházy E, Balonová T, Durisová M, Gajdosík A, Jansák J, Molnárová A.

Neoplasma. 1993;40(1):45-9.

PMID:
8350947
37.

Pharmacokinetics of heptacaine, a novel potent local anaesthetic agent, after rectal administration to rats.

Faberová V, Durisová M, Trnovec T, Divisová D.

Eur J Drug Metab Pharmacokinet. 1992 Jul-Sep;17(3):227-32.

PMID:
1490492
38.

Effect of the cardioprotective agent stobadine on reproduction in rats.

Balonová T, Ujházy E, Nosál R, Durisová M, Jakubovský J, Líska J.

Bratisl Lek Listy. 1991 Dec;92(12):603-8.

PMID:
1806176
39.

Reproductive toxicity studies with cis-(-)-2,3,4,4a,5,9b-hexahydro-2,8-dimethyl-1H-pyrido-[4,3-b]indole dipalmitate in rats.

Balonová T, Zeljenková D, Durisová M, Nosál R, Jakubovský J, Líska J, Stolc S.

Arzneimittelforschung. 1991 Jan;41(1):1-5.

PMID:
2049110
40.

The effect of high energy electron irradiation on blood-brain barrier permeability to haloperidol and stobadin in rats.

Trnovec T, Volenec K, Bezek S, Kállay Z, Durisová M, Scasnár V, Kubu M, Svoboda V.

Radiat Environ Biophys. 1991;30(4):277-87.

PMID:
1683710
41.

Effect of gamma-irradiation on disposition of the local anaesthetic, carbisocaine in rabbits.

Kállay Z, Durisová M, Trnovec T, Svoboda V.

J Pharm Pharmacol. 1990 Dec;42(12):871-3.

PMID:
1983152
42.

Irradiation of the head by 60Co opens the blood-brain barrier for drugs in rats.

Bezek S, Trnovec T, Scasnár V, Durisová M, Kukan M, Kállay Z, Laginová V, Svoboda V.

Experientia. 1990 Oct 15;46(10):1017-20.

PMID:
2226715
43.

[Characteristics of new approaches for evaluation of embryotoxic effects of chemical substances].

Balonová T, Ujházy E, Nosál' R, Durisová M, Zeljenková D.

Bratisl Lek Listy. 1990 Aug;91(8):593-600. Slovak.

PMID:
2207730
44.

Effects of inducers and inhibitors of mixed-function oxidases on the biliary excretion of pentacaine metabolites.

Kukan M, Bezek S, Scasnár V, Durisová M, Trnovec T.

Biopharm Drug Dispos. 1990 Jul;11(5):395-401.

PMID:
2207293
45.

Survival after intramuscular or inhalation administration of gentamicin in neutropenic guinea pigs infected by Klebsiella pneumoniae.

Trnovec T, Kállay Z, Durisová M, Bezek S, Navarová J.

J Antimicrob Chemother. 1990 Jan;25(1):127-32.

PMID:
2180888
46.

The effect of enzyme induction and inhibition on the disposition of the xanthine-related nootropic drug ethimizol in perfused liver and hepatocytes of rats.

Kukan M, Bezek S, Stefek M, Trnovec T, Durisová M, Piotrovskiy LB.

Drug Metab Dispos. 1990 Jan-Feb;18(1):96-101.

PMID:
1970784
47.

Teratological study of the hypolipidaemic drugs etofylline clofibrate (VULM) and fenofibrate in Swiss mice.

Ujházy E, Onderová E, Horáková M, Bencová E, Durisová M, Nosál R, Balonová T, Zeljenková D.

Pharmacol Toxicol. 1989 Mar;64(3):286-90.

PMID:
2726692
48.

Distribution of chloroquine in human blood fractions.

Nosál R, Ericsson O, Sjöqvist F, Durisová M.

Methods Find Exp Clin Pharmacol. 1988 Sep;10(9):581-7.

PMID:
3226224
49.

BEQUIV interactive microcomputer program for testing equivalence in two-group comparative bioavailability trials.

Durisová M, Trnovec T.

Methods Find Exp Clin Pharmacol. 1988 Feb;10(2):129-33.

PMID:
3361979
50.

Pharmacokinetics of carbisocaine in rats and mice.

Bezek S, Faberová V, Scasnár V, Trnovec T, Durisová M, Kállay Z.

Eur J Drug Metab Pharmacokinet. 1988 Jan-Mar;13(1):27-34.

PMID:
3396611

Supplemental Content

Loading ...
Support Center